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Abstract
Background: The purpose of the study was to determine whether inclusion of computerized tomography (CT) in
the prospective evaluation of vulvar cancer changed the surgical treatment strategy in terms of detection of lymph
node metastases, tumor spread and comorbidity, and additionally to examine the logistical influence of adding
further examinations prior to treating out-hospital patients referred from geographically distant areas.
Methods: During an 8 month period we conducted a prospective study of patients with newly diagnosed or
recurrent vulvar cancer consecutively referred to Copenhagen University Hospital, Rigshospitalet. The patients
underwent a gynecological examination, chest x-ray and a preoperative CT scanning of the chest, abdomen
and pelvis. It was registered whether the radiological findings regarding the extent of the tumor, lymph node
involvement, incidental findings and comorbidity changed the surgical treatment plan. Further, the logistical
influence of the long referral distances was registered.
Results: Thirty patients with a median age of 69 years (range 44–93 years) were included in the study. CT did not
significantly change the initial surgical treatment plan for the patients. CT did not reveal lymph node enlargement
outside the inguinofemoral area and was inaccurate compared to the sentinal node examination of the local
lymph nodes. CT diagnosed no cases with distant metastases from the primary malignancy, but two cases with a
secondary malignant disease were found.
Conclusions: CT scanning has no clinical impact as a routine screening examination prior to surgery. It may delay
treatment, but can add important information when clinically indicated.
Keywords: Computerized tomography, Staging, Vulvar cancer, Comorbidity, Logistics, Sentinel node, Incidental
findings
Background
Vulvar cancer is a rare malignancy of the external genitals
in adult women. The incidence of the disease in Denmark
is 80–100 annually and the patients are generally elderly
women, with a median age of 65 years [1]. Due to the ad-
vanced age of the patients, the prevalence of comorbidity
is relatively high [2, 3]. In accordance with the treatment
guidelines of the ongoing Groningen International Study
on Sentinel Nodes in Vulvar Cancer II (GROINSS-V II)
[4], the primary treatment of clinically localized vulvar
cancer consists of partial or total vulvectomy. Spread to
the inguinal lymph nodes is evaluated either by the senti-
nel node procedure (vulvar tumor ≤4 cm and no clinical
signs of tumor spread to inguinal nodes) or lymphadenec-
tomy of the regional lymph nodes. Danish guidelines used
for treatment planning include preoperative gynecological
examination and imaging techniques, such as chest x-ray,
abdominal or transvaginal ultrasound (UL), and in individ-
ual cases either computerized tomography (CT), positron
emission tomography (PET) or magnetic resonance im-
aging (MRI) [5]. Outside Denmark, these supplementary
cross-sectional imaging modalities are recommended rou-
tinely [6, 7]. However, the literature is scarce regarding the
benefit of these preoperative examinations for the decisive
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surgical procedure and the final outcome of the patients, in-
cluding identification of lymph node metastases and prob-
able comorbidity and incidental findings detected [8–11].
The final stage of the disease is determined by the combined
gynecological, pathological and radiological findings, in ac-
cordance to the revised guidelines proposed by the Inter-
national Federation of Gynecology and Obstetrics (FIGO)
[12, 13]. Of special importance is, whether identified comor-
bidity and incidental findings will moderate or change the
scheduled surgical treatment plan or follow-up[14].
In Denmark, treatment has been centralized to two de-
partments, and thus the uptake of patients with vulvar
cancer covers a large geographical area. The Gynecological
Department, receives patients from the eastern and south-
ern part of Denmark, resulting in long travel distances for a
significant number of the patients. The logistics of add-
itional examinations to the existing scheduled procedures
might be expensive, time consuming and eventually delay-
ing surgery.
The primary goal of the study was to investigate the
clinical impact of adding a preoperative CT scan in the
evaluation of invasiveness of the tumor, metastatic
spread or incidental abnormalities that might influence
the scheduled surgical plan.
Methods
We performed a prospective study of women consecutively
referred to the Gynecological Department at Copenhagen
University Hospital, Rigshospitalet, between July 2012 and
February 2013. All patients were newly diagnosed with his-
tologically confirmed vulvar carcinoma or recurrence of a
vulvar cancer, previously treated and considered cured. The
patients were clinically examined by the same two gynecol-
ogists (IT and VZ), and the surgical plan was decided ac-
cording to the Danish guidelines. For all patients this was
noted in a prospective registration form. The patient infor-
mation and strategy described in the registration form
followed the patient to the radiologists, who performed a
CT scan of the chest, abdomen and pelvis. Concomitantly,
chest x-ray examination was performed as a part of the
usual preoperative workup. The equipment for CT scan in-
cluded in all cases a 64-slice multidetector CT scanner
(MDCT), and all patients received intravenous and orally
administered contrast agent. It was a prerequisite that the
serum creatinine was known. All scans were supervised by
the same radiologists (KA and KDP) and analyzed within
two days. The CT diagnoses included the extension of the
primary tumor in the vulvar region, tumor size, degree of
invasiveness and especially the relationship to the urethra.
The lymph node size, appearance and contrast enhance-
ment was analyzed in the superficial inguinofemoral area,
in the minor pelvis and in the retroperitoneal space. On CT
scan a lymph node was regarded as malignant if the min-
imal short axis diameter was exceeding 10 mm in the axial
plane, and/or if it presented with an abnormal pattern of
contrast enhancement. The analysis further included signs
of metastases in the lungs, mediastinum, abdominal organs
or bones. Abnormal findings were described in the patient
registration form. Finally, the preoperative clinical findings
and plan were correlated to the CT findings at an internal
conference prior to surgical treatment of the patient. It was
noted whether the CT scan changed the initial surgical
treatment strategy, including uni- or bilateral sentinel node
examination–or in certain cases lymphadenectomy. Fur-
ther, whether the CT scan visualized important incidental
findings influencing the final treatment plan, and finally
whether adding a CT scan would delay surgery for the out-
hospital patients. The study is in compliance with the
Helsinki Declaration. The patients were treated according
to the Danish Guidelines for treatment of vulva cancer,
which request a CT-, MR- or PET-CT scan preoperatively
and the results of the CT scans were revealed to the sur-
geons pre-operatively. All patients gave written consent to
participate in the study and for the results to be published.
Results
Thirty consecutive patients with newly diagnosed or re-
current vulvar cancer were referred to the gynecological
department during the eight month period. Twenty-seven
patients were included in the study and all data are listed
in Table 1. Three patients were excluded due to lack of a
registration form (one patient) or intolerance of the intra-
venous contrast agent (two patients). The median age of
the patients was 69 years (range 44–93 years). A small ma-
jority (56 %) of the patients were referred from outside the
Copenhagen area (southern and eastern part of Denmark).
With some exceptions, all patients were scheduled for a
CT scan on the same day or the day after the initial exam-
ination (weekends and holidays not included). Chest x-ray
was performed with a median of 10 days (range 0–21
days) after the initial examination, and surgery was per-
formed with a median of 12 days later (range 0–22 days).
Twenty-three of the patients had newly diagnosed vulvar
carcinoma and four had recurrence of the disease. Ac-
cording to the gynecological examination, the tumor size
was below 4 cm in 23 cases, and exceeding 4 cm in the
remaining four cases. Twenty-one patients were registered
as suffering from various forms of comorbidity, e.g. hyper-
tension, hyperthyroidism and diabetes. The initial clinical
stage and final stage according to the FIGO classification
is listed in Table 2. A total of five patients were upstaged
following surgery, lymph node examination and histopath-
ology due to metastatic spread to the inguinal nodes, thus
the number of patients with stage I/II was reduced from
24 to 19. However, the findings did not influence the ini-
tial surgical treatment strategy. Imaging included chest x-
ray and MDCT. Chest x-ray was performed in 24 of the
27 patients. The three exceptions were due to lack of
Andersen et al. Cancer Imaging  (2015) 15:8 Page 2 of 6
attendance for unknown reasons. Thirteen examinations
were normal, ten demonstrated findings of minor clinical
importance, and in one case chest x-ray unexpectedly re-
vealed pulmonary nodules, later shown to represent me-
tastases from an asymptomatic unknown adenocarcinoma
of the cecum, visualized by CT. Chest x-ray did not
change the initial gynecological treatment strategy for any
of the patients.
CT scan of the chest, abdomen and pelvis was performed
on all 27 patients (Table 1). Local invasiveness regarding in-
volvement of the urethra was indicated in three patients.
No distant metastases originating from the primary vulvar
tumor were found. In seven patients a total of eight ipsilat-
eral lymph nodes with enlargement/hyperdensity after
intravenous contrast were found in the groin on the CT
scanning. However, the ability of the observer to correctly
identify groin lymph node metastases on a CT scan com-
pared to histological examination was poor, with a sensitiv-
ity of 60 %, specificity of 90 %, positive predictive value of
37.5 % and negative predictive value of 95.7 % (Table 3).
Due to clinical findings, the treatment plan was changed
in two cases (Table 4), indicating supplementary imaging
(PET/CT, MRI) (Fig. 1a and b). The screening CT scan did
not itself influence the treatment strategy in the study. The
incidental abnormalities visualized by the CT scan were
classified according to their potential clinical significance as
of major, moderate or minor importance (Table 1). Two
cases of incidental synchronous malignancies were found:
one woman (age 61 years) with a cecal tumor with pulmon-
ary metastases and one woman (age 56 years) with a renal
tumor. In three cases, suspected pathological findings later
proved to be benign. Finally, CT did not cause delay of sur-
gery for any of the long distance, out-hospital patients.
However, planning and logistics was troublesome and CT
scan was omitted in this prospective study in three patients,
due to missing creatinine values prior to the scan and insuf-
ficient coordination between the two departments involved
in the study, and thus these patients were excluded from
the study.
Discussion
Preoperative CT scan of patients with localized vulvar car-
cinoma did not change the initial treatment strategy for any
of the patients, nor did the high proportion of incidental
Table 1 Characteristics of 27 women with vulvar cancer
Clinical characteristics (n = 27) Median IQR
Age (years) 69a 22b
Time from initial examination to intervention
CT (days) 6a 5b
Chest x-ray (days) 10a 7b
Surgery (days) 12a 8b
Catchment area n %
Regional 12 44 %
Extra-regionalc 15 56 %
Initial gynecological examination
Recurrence 4 15 %
Debut 23 85 %
Clinically registered comorbidity 21 78 %
Tumor size >4 cm 4 15 %
Incidental findings on CT
No incidental findings 1 4 %
Minor and moderate importanced 21 78 %
Major importancee 3 11 %
Confirmed cancersf 2 7 %
Histology
Squamous cell carcinoma 26 96 %
Basosquamous carcinoma 1 4 %
a,b Data are summarized as median values and interquartile ranges (IQR)
cSouthern and eastern part of Denmark
dOne or more findings of minor and moderate importance, i.g. atherosclerosis,
cholecystolithiasis, simple renal- and hepatic cysts, diverticula and
hiatus hernia
eFindings of major importance were pulmonary nodules, an endometrial polyp
and biliary ectasia
fRenal cell carcinoma and adenocarcinoma of the cecum with
pulmonary metastases
Table 2 Pre- and final postoperative stage of 27 women with
vulvar cancer
Preoperative and final postoperative stage (n = 27) Number Percent
Initial FIGO stage
IA 1 4 %
IB 20 74 %
II 3 11 %
III 3 11 %
IV 0 0 %
Final FIGO stage
IA 1 4 %
IB 17 63 %
II 1 4 %
III 7 26 %
IV 1 4 %
Table 3 Number of groin dissections (n). Histological
examination of the specimen determined true nodal status
Accuracy of CT in detecting lymph node metastases in the groin
Abnormal on histological
examination (n = 10)
Normal on histological
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findings on CT, including two cases of confirmed synchron-
ous cancer. However, in some cases CT confirmed regional
tumor spread found at the gynecological examination. This
is in accordance with a retrospective study, which could
not recommend a CT scan in the preoperative examination
of vulvar carcinoma, due to low sensitivity and specificity in
the diagnosis of lymph node metastases [11]. Preoperative
palpation of the groin [15] and other imaging modalities,
such as PET/CT [8, 9] and MRI [10], have also shown to be
inaccurate in the detection of inguinal lymph node metasta-
ses. Currently, the only technique that appear to be effective
in the detection of lymph node metastases, is either the
sentinel node procedure or inguinal femoral lymphadenec-
tomy [16, 17]. The incidental finding on the CT scanning of
a synchronous renal tumor and a cecal tumor with pul-
monary metastases, contributed to earlier intervention and
treatment of these malignancies. Few studies exist of the
frequency and clinical significance of incidental findings on
CT scans. A systematic review reported the frequency of in-
cidental findings on CT scans to be 31.1 % [18], whereas
another systematic review reported clinically important
findings in 7–12 % of cases [19]. In a recent retrospective
study of incidental findings on CT scans of patients with
prostate cancer, 20.6 % of all findings were potentially of
clinical significance. Synchronous malignancy was detected
in 5.9 % of patients, of which renal cancer was the most
common (2.0 %) and colon cancer was found in 0.8 % of
patients [20]. Taking into account the relatively small sam-
ple size and the population characteristics in the current
study, the prevalence of all incidental findings (n = 26),
renal cancer (n = 1) and colon cancer (n = 1) is comparable
to that of similar studies. The benefits of managing inci-
dental findings on CT have to be balanced to the cost,
time consumption and potentially harmful consequences
of further tests and treatments. At present, no studies rec-
ommend primary screening with a CT scan in any popula-
tion group.
The median time intervals from the initial examination
to imaging and surgical treatment were within the ac-
cepted range according to Danish guidelines. Though not
Table 4 Impact of preoperative examinations and CT scans on surgical strategy





CT changing treatment plan, n
Vulvectomy and unilateral SNLa
dissection
7 7 No changeb
Vulvectomy and bilateral SNL
dissection
13 13 No changec
Vulvectomy and bilateral
lymphadenectomy
1 1 No changed
Surgery and radiotherapy or primary
radiotherapy





dVulvectomy and unilateral lymphadenectomy
ePrimary radiotherapy, due to invasion of the ilium (patient one). Vulvectomy and radiotherapy, due to pulmonary metastases from an adenocarcinoma of the
caecum (patient two)
Fig. 1 a A 56 year old woman with a left-sided vulvar carcinoma (lower arrow), palpable inguinal nodes and the corresponding CT scan showing
metastases with enlargement and contrast enhancement (upper arrow). b A 74 year old woman with unexpected invasion of the ilium by lymph
node metastases (arrow), clinically regarded resectable prior to surgery
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quantified, due to limited CT scan capacity, the investiga-
tors spend a considerable amount of time planning and
executing the CT scans, as well as adjusting for unforeseen
events.
The study is limited by the relatively low number of
patients included. This is primarily due to the low inci-
dence of the disease in Denmark and the fact that only ap-
proximately half of all the Danish patients are referred to
our institution. The cost of routinely adding a preopera-
tive CT scan is not feasible, especially as the benefit of the
rather time consuming procedure was low. However, any
patient with surgically proven inguinal lymph node metas-
tasis should have further imaging in order to plan the
postoperative oncological treatment.
Conclusions
If clinically feasible, surgery is mandatory in the treatment
of vulvar cancer. Chest x-ray and clinical evaluation sup-
plemented with sentinel node examination for local lymph
node involvement is generally sufficient in patients with-
out signs of advanced disease. This prospective study of
evaluating a preoperative supplementary screening CT
scan of the chest, abdomen and pelvis showed no clinical
impact in patients without clinical indications for further
imaging procedure added to the existing strategy. It did
not detect unsuspected dissemination, it was inaccurate in
the evaluation of lymph nodes, and it might delay the final
surgery. In cases with advanced disease or when clinically
indicated by pathological proven spread to the inguinal
lymph nodes, CT scan–as other imaging techniques–can
offer valuable information.
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